Skip to main content
Caplight Logo









Claimeye

Claimeye

Private
United StatesHealthcare & Life Scienceshttps://www.claimeye.com/

Last Round

Seed

Jan 21, 2026

Total Funding Raised

$4.9M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Claimeye is a health technology company that provides a mobile and web-based suite of solutions to facilitate and expedite the submission of out-of-network medical claims for patients, providers, and health plans.

Sector

Healthcare & Life Sciences

Verticals

InsurTech, Revenue Cycle, Patient Engagement, Workflow Automation

Business Model

B2B2C

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

medical claims processingout-of-network claimsrevenue cycle managementRCMmedical billing softwareclaims automationOCRoptical character recognitionthird-party administratorTPApatient reimbursementhealth insurance claimsmedical superbillinsurtechclaims managementmedical billing automationclaims clearinghouse

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Claimeye Comparables

Compare Claimeye with similar companies based on industry and business-model similarity.

Claimeye comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Reimbursify
91%
Mentaya
82%
Thrizer
82%

Claimeye Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 21, 2026
AcceleratorJun 1, 2025

Claimeye Investors

Notable investors and investment history

Claimeye investors
InvestorRounds
Maverick VenturesSeed
Peak XV PartnersSeed
Y CombinatorAccelerator, Seed
DHVP (Digital Health Venture Partners)Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors grew 959% MoM, reaching 1.5K.

  • Jan 21, 2026

    $4.4M round led by Maverick Ventures.

Claimeye Filings

Explore SEC and related filing metadata, where available.

Claimeye filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Claimeye's valuation, stock price, and market status.

Is Claimeye a public or private company?

Claimeye is a private company.

What is the current stock price of Claimeye?

Claimeye is a private company with no public stock price. Caplight tracks Claimeye's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Claimeye worth (valuation)?

Valuation information for Claimeye is not publicly available.

Can I buy Claimeye stock?

Claimeye shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Claimeye's last funding round?

Claimeye's most recent funding round was Seed on January 21, 2026.

Who are the main investors in Claimeye?

Key investors in Claimeye include Maverick Ventures.

Will Claimeye IPO soon?

No public IPO plans have been announced for Claimeye.

How can I track Claimeye secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Claimeye's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersUnited States
Year Founded2017
Last FundingJan 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?